Malaysian
Bio-Diagnostics Research Sdn Bhd (MBDr) was incorporated
in 1994 and began operations in September 1995.
Initially
established as a company to commercialise research undertaken
on diagnosis of typhoid fever, MBDr has expanded into
producing various other medical diagnostics products
amongst others, pregnancy test, drugs of abuse test and
brugian filariasis.
Through
the strategic partnerships with various Universities
and Research Institutes, MBDr is currently developing
new medical diagnostic products for the detection of
various diseases such as, tuberculosis, malaria, HIV,
paratyphoid, Nipah virus and dengue.
MBDr
aims to position itself as a global leader in developing
and marketing diagnostic tests, providing a strong foundation
for diagnostics and treatment decisions.
"We
actively collaborate with leaders, researchers and clinicians
around the world to review current trends and address
gaps in the field of medical diagnostics. We leverage
our collaborations to develop and deliver tools that
target identified unmet needs in diagnostic testing," says
Emeri Johari, CEO of MBDr.
Core
Activities
|
